A Comparative Study of Allopathy and Ayurveda Medicines in the Treatment of Type 2 Diabetes Mellitus and its Clinical Impact

被引:0
|
作者
Bindu, Radhika [1 ]
Dharamsi, Abhay [2 ]
机构
[1] Parul Univ, Parul Inst Pharm, Dept Pharm Practice, Fac Pharm, Vadodara, Gujarat, India
[2] Parul Univ, Fac Pharm, Parul Inst Pharm, Dept Pharmaceut, Vadodara, Gujarat, India
关键词
Allopathy; Ayurveda; Clinical Impact; Comparative study; Diabetes Mellitus;
D O I
10.5530/jyp.2023.15.104
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Type 2 Diabetes Mellitus (T2DM) is a complex disorder that has major health and economic consequences. Human beings have been using the herbal and allopathic systems of medicine since a long time to cure, treat, diagnose and prevent various disease and ailments. One such example is T2DM. In Ayurveda, the corresponding term for Diabetes is "Madhumeha" Unlike the ayurvedic system; the allopathic method is more scientifically proven, regulated and developed since decades. Aim: This work comparatively analyzes the Allopathic and Ayurveda treatment in T2DM patients. Materials and Methods: A Prospective Longitudinal Study was conducted in 2 tertiary care teaching hospitals that enrolled 100 patients each in Allopathy and Ayurveda groups. Results: Out of 200 patients, male patients were higher in number. The prevalence was higher in the 50 - 60 years age group which has been a greater risk factor for developing diabetes. We have used the Kuppuswamy Scale for the socio- economic categorization in this study and found Lower Middle-class patients were higher in the Allopathy study group and Upper Lower- class patients were dominant in the Ayurveda study group. Conclusion: Better glycemic control was achieved with the Allopathy group over Ayurveda group (p Value: 0.0468*). Random Blood Sugar levels were reduced in the allopathy group which was statistically significant (p Value: 0.0308*) compared to the Ayurveda group.
引用
收藏
页码:755 / 759
页数:5
相关论文
共 50 条
  • [41] Vildagliptin: the evidence for its place in the treatment of type 2 diabetes mellitus
    Profit, Louise
    Chrisp, Paul
    Nadin, Carole
    CORE EVIDENCE, 2008, 3 : 13 - 30
  • [43] The treatment of type 1 diabetes mellitus with agents approved for type 2 diabetes mellitus
    Munir, Kashif M.
    Davis, Stephen N.
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (15) : 2331 - 2341
  • [44] Clinical impact and health economic consequences of posttransplant type 2 diabetes mellitus
    Chilcott, JB
    Whitby, SM
    Moore, R
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (5A) : 32S - 39S
  • [45] Normal Weight Central Obesity and its Impact on Type 2 Diabetes Mellitus
    Bai, Jing
    Zhang, Yifan
    He, Li
    Zhao, Yang
    CURRENT DIABETES REPORTS, 2025, 25 (01)
  • [46] Canagliflozin monotherapy: clinical study data in type 2 diabetes mellitus
    Matthaei, S.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2014, 139 : S59 - S64
  • [47] Gemigliptin: An Update of Its Clinical Use in the Management of Type 2 Diabetes Mellitus
    Kim, Sung-Ho
    Yoo, Jung-Hwa
    Lee, Woo Je
    Park, Cheol-Young
    DIABETES & METABOLISM JOURNAL, 2016, 40 (05) : 339 - 353
  • [48] A CLINICAL STUDY OF RHEUMATOLOGICAL MANIFESTATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Venkataravanappa, Vineetha Kolar
    Huchappa, Anand Sorikunte
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2015, 4 (103): : 16890 - 16898
  • [49] BUDGET IMPACT ANALYSIS OF DAPAGLIFLOZIN FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS IN CHINA
    Liu, C.
    Xie, S.
    Wu, J.
    VALUE IN HEALTH, 2018, 21 : S37 - S37
  • [50] The impact of depressive symptoms on treatment satisfaction of patients with type 2 diabetes mellitus
    Papadopoulos, A. A.
    Papadopoulos, A. E.
    Pappa, E.
    Niakas, D.
    ARCHIVES OF HELLENIC MEDICINE, 2016, 33 (02): : 224 - 230